Annie SCHREIJER-PIERIK

Pays-Bas Mandat terminé
Pays-Bas
18 973 votes enregistrés
77% taux de participation

Répartition des votes

Pour
43% (8231)
Contre
32% (6114)
Abstention
1% (227)
Absent
23% (4401)

Historique des groupes

EPP European People’s Party 02/07/2019 → 15/07/2024

Votes 14 572 au total

09/07/2020 The EU’s public health strategy post-COVID-19 ✓ Adopté ▲ Pour 09/07/2020 The EU’s public health strategy post-COVID-19 ✓ Adopté ▲ Pour 09/07/2020 The EU’s public health strategy post-COVID-19 ✓ Adopté ▲ Pour 09/07/2020 The EU’s public health strategy post-COVID-19 ✓ Adopté ▲ Pour 09/07/2020 The EU’s public health strategy post-COVID-19 ✓ Adopté ▲ Pour 09/07/2020 The EU’s public health strategy post-COVID-19 ✓ Adopté ▲ Pour 09/07/2020 The EU’s public health strategy post-COVID-19 ✓ Adopté ▲ Pour 09/07/2020 The EU’s public health strategy post-COVID-19 ✓ Adopté ▲ Pour 09/07/2020 The EU’s public health strategy post-COVID-19 ✓ Adopté ▲ Pour 09/07/2020 The EU’s public health strategy post-COVID-19 ✓ Adopté ▲ Pour 09/07/2020 The EU’s public health strategy post-COVID-19 ✓ Adopté ▲ Pour 09/07/2020 The EU’s public health strategy post-COVID-19 ✓ Adopté ▲ Pour 09/07/2020 The EU’s public health strategy post-COVID-19 ✓ Adopté ▲ Pour 09/07/2020 The EU’s public health strategy post-COVID-19 ✓ Adopté ▲ Pour 09/07/2020 VAT e-commerce package – distance sales of goods and services: postponement of the date of application due to the outbreak of the COVID-19 crisis ✓ Adopté ▲ Pour 09/07/2020 Financial activities of the European Investment Bank - annual report 2019 ✓ Adopté ▲ Pour 09/07/2020 Control of the financial activities of the European Investment Bank - annual report 2018 ✓ Adopté ▲ Pour 09/07/2020 Protection of the European Union's finacial interests - combating fraud - annual report 2018 ✓ Adopté ▲ Pour 09/07/2020 The humanitarian situation in Venezuela and the migration and refugee crisis ✓ Adopté ▲ Pour 09/07/2020 The draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, dimethomorph, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, formetanate, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole and S-metolachlor ✓ Adopté ▼ Contre